A Virtual Reality View: Moderate-to-Severe Atopic Dermatitis: Long-Term Treatment and Managed Care Issues

REGISTER NOW!
Already Registered?
SIGN IN

WEBCAST DATE

Tuesday, April 30, 2019

3:00 PM Eastern    2:00 PM Central    1:00 PM Mountain    12:00 PM Pacific

PROGRAM FEATURES

• Virtual reality headsets provided to attendees for viewing this presentation only
• Create your own personalized poster
• Interactive, case-based learning environment

FACULTY

Geoffrey C. Wall, PharmD, FCCP, BCPS
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Consulting Partner
Medical Intelligence Group, PLLC
Des Moines, IA

Jonathan I. Silverberg, MD, PhD, MPH
Assistant Professor of Dermatology
Medical Social Sciences and Preventive Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL

AGENDA

I. AD in Pediatric Patients: An Overview
  a. Epidemiology and Burden
  b. Pathophysiology
  c. Comorbid conditions

II. Challenges in the Diagnosis and Management of AD in Pediatric Patients
  a. Utility of biomarkers for diagnosis and treatment response
  b. Inconsistent management patterns
  c. Selection of optimal front-line therapy for each patient based on traditional standard of care treatment approaches and types of treatment regimens
  d. Non-adherence as a barrier to effective management
  e. Effect of management decisions on patient QoL

III. Newly-approved and Emerging Targeted Therapeutic Agents for the Management of AD in Pediatric Patients
  a. Topical agents
  b. Biologics
  c. Small molecules

IV. Discuss the benefits of patient-centered health care management teams for pediatric patients with AD and the respective roles of team members
  a. Analysis of relevant patient factors
  b. Evidence suggesting the benefits of a patient-centered, team-based management approach
  c. Team members and their respective roles
  d. Unique Role of Community Pharmacists

V. Case Study

VI. Conclusions

LEARNING OBJECTIVES

After completing the educational activity, learners should be better able to:

• Review recent pathophysiological findings in AD that have informed the selection of new therapeutic targets
• Describe best practices for severity assessment and diagnosis of moderate-to-severe AD in adult and pediatric patients, accounting for biomarkers, phenotype/genotype, comorbidities, and disease burden
• Explain the mechanisms-of-action and clinical profiles of new and emerging targeted systemic agents for the long-term treatment of AD in adult and pediatric patients
• Discuss how different biomarkers, comorbidities and adherence barriers play a role in long-term treatment decision making for adult and pediatric patients with AD

TARGET AUDIENCE

This activity is intended for US-based pharmacists, managed care professionals, pediatric dermatologists and other healthcare professions who diagnose, treat, and/or manage patients with AD

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with atopic dermatitis.

CNE Credits:1.5 ANCC Contact Hour(s)

CNE Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

PHARMACY CREDIT INFORMATION

AMEDCO is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualifies for up to 1.5 contact hours. Full attendance is required. No partial contact hours will be awarded for partial attendance.
UAN: Pharmacists: ###; Pharmacy Technician: ##

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.